GoldenGolden
Ascletis Pharma

Ascletis Pharma

A biotechnology company that develops and discovers anti-viral drugs and treatments for cancer and fatty liver disease. Ascletis is a joint venture between entrepreneurs in the U.S. and China.

All edits

Edits on 20 Jul, 2020
Edita Rexha
Edita Rexha approved a suggestion from Golden's AI on 20 Jul, 2020
Edits made to:
Article (+6/-6 characters)
Article

Ascletis’s Ganovo, an oral inhibitor of Hepatitis C protease and ritonavir a protease inhibitor from AbbVieAbbVie were used in combination in a clinical trial at the Ninth Hospital of Nanchang, China, led by Dr. Hongyi Chen, for treatment of COVID-19. Three patients were discharged after the treatment as of February 27, 2020. Ganovo received approval from China’s National Medical Products Administration in June, 2018 for treatment of Hepatitis C. The company’s protease inhibitor ASC09 is also in clinical trials in combination with other drugs for treatment of COVID-19.

Edits on 16 Jul, 2020
Neelam Jhaveri"Approved suggestion #884339"
Neelam Jhaveri edited on 16 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
CEO
Jinzi J. Wu
Edits on 13 Mar, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 13 Mar, 2020
Edits made to:
Article (+17/-17 characters)
Article

Since the outbreak of COVID-19, Ascletis Pharma has announced that they are treating three patients treated with Ganovo plus Ritonavir as part of a novel coronavirus pneumonia clinical trial that occured in China and were dischared from the hospital. Ganovo is a oral inhibitor of Hepatitis C virusHepatitis C virus and is approved by the FDA to treat HIV infections in people. The company looks to work with the patients that were discharged to develop anti-viral drugs to be used in clinical studies on the treatment of HCP.

Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 13 Mar, 2020
Edits made to:
Article (+3/-3 characters)
Article

Since the outbreak of COVID-19, Ascletis Pharma has announced that they are treating three patients treated with Ganovo plus Ritonavir as part of a novel coronavirus pneumonia clinical trial that occured in China and were dischared from the hospital. Ganovo is a oral inhibitor of Hepatitis C virus and is approved by the FDA to treat HIVHIV infections in people. The company looks to work with the patients that were discharged to develop anti-viral drugs to be used in clinical studies on the treatment of HCP.

Edits on 13 Mar, 2020
Charlie Hilton
Charlie Hilton approved a suggestion from Golden's AI on 13 Mar, 2020
Edits made to:
Article (+14/-14 characters)
Article

Ascletis’s Ganovo, an oral inhibitor of Hepatitis C protease and ritonavir a protease inhibitor from AbbVie were used in combination in a clinical trialclinical trial at the Ninth Hospital of Nanchang, China, led by Dr. Hongyi Chen, for treatment of COVID-19. Three patients were discharged after the treatment as of February 27, 2020. Ganovo received approval from China’s National Medical Products Administration in June, 2018 for treatment of Hepatitis C. The company’s protease inhibitor ASC09 is also in clinical trials in combination with other drugs for treatment of COVID-19.

Daniel Frumkin"added to article for COVID-19 information"
Daniel Frumkin edited on 12 Mar, 2020
Edits made to:
Article (+517 characters)
Article

COVID-19

Since the outbreak of COVID-19, Ascletis Pharma has announced that they are treating three patients treated with Ganovo plus Ritonavir as part of a novel coronavirus pneumonia clinical trial that occured in China and were dischared from the hospital. Ganovo is a oral inhibitor of Hepatitis C virus and is approved by the FDA to treat HIV infections in people. The company looks to work with the patients that were discharged to develop anti-viral drugs to be used in clinical studies on the treatment of HCP.

Edits on 28 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 28 Feb, 2020
Edits made to:
Article (+5/-5 characters)
Article

Ascletis’s Ganovo, an oral inhibitor of Hepatitis C protease and ritonavir a protease inhibitor from AbbVie were used in combination in a clinical trial at the Ninth Hospital of Nanchang, ChinaChina, led by Dr. Hongyi Chen, for treatment of COVID-19. Three patients were discharged after the treatment as of February 27, 2020. Ganovo received approval from China’s National Medical Products Administration in June, 2018 for treatment of Hepatitis C. The company’s protease inhibitor ASC09 is also in clinical trials in combination with other drugs for treatment of COVID-19.

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 28 Feb, 2020
Edits made to:
Article (+11/-11 characters)
Article

Ascletis’s Ganovo, an oral inhibitor of Hepatitis CHepatitis C protease and ritonavir a protease inhibitor from AbbVie were used in combination in a clinical trial at the Ninth Hospital of Nanchang, China, led by Dr. Hongyi Chen, for treatment of COVID-19. Three patients were discharged after the treatment as of February 27, 2020. Ganovo received approval from China’s National Medical Products Administration in June, 2018 for treatment of Hepatitis C. The company’s protease inhibitor ASC09 is also in clinical trials in combination with other drugs for treatment of COVID-19.

Edits on 27 Feb, 2020
Meredith Hanel
Meredith Hanel edited on 27 Feb, 2020
Edits made to:
Infobox (+1 properties)
Article (+160/-2 characters)
Article

Ascletis’s Ganovo, an oral inhibitor of Hepatitis C protease and ritonavir a protease inhibitor from AbbVie were used in combination in a clinical trial at the Ninth Hospital of Nanchang, China, led by Dr. Hongyi Chen, for treatment of COVID-19. Three patients were discharged after the treatment as of February 27, 2020. Ganovo received approval from China’s National Medical Products Administration in June, 2018 for treatment of Hepatitis CC. The company’s protease inhibitor ASC09 is also in clinical trials in combination with other drugs for treatment of COVID-19.

Infobox
Location
Hangzhou
Meredith Hanel
Meredith Hanel edited on 27 Feb, 2020
Edits made to:
Infobox (+3 properties)
Description (+192 characters)
Article (+623 characters)
People (+1 rows) (+2 cells) (+16 characters)
Categories (+2 topics)
Topic thumbnail

Ascletis Ascletis Pharma

A biotechnology company that develops and discovers anti-viral drugs and treatments for cancer and fatty liver disease. Ascletis is a joint venture between entrepreneurs in the U.S. and China.

Article

Ascletis Pharma is a biotechnology company that develops and discovers anti-viral drugs and treatments for cancer and fatty liver disease. Ascletis is a joint venture between entrepreneurs in the U.S. and China.

...

Ascletis’s Ganovo, an oral inhibitor of Hepatitis C protease and ritonavir a protease inhibitor from AbbVie were used in combination in a clinical trial at the Ninth Hospital of Nanchang, China, led by Dr. Hongyi Chen. Three patients were discharged after the treatment as of February 27. Ganovo received approval from China’s National Medical Products Administration in June, 2018 for treatment of Hepatitis C.

People

Name
Role
LinkedIn

Jinzi Wu

Founder

Infobox
Founded date
2011
Industry
Biotechnology
Location
Jianghan
Categories
Edits on 8 Jul, 2019
Golden AI"Remove default description"
Golden AI edited on 8 Jul, 2019
Edits made to:
Description (-7 characters)
Topic thumbnail

Ascletis Pharma

Company

Edits on 9 May, 2019
Neelam Jhaveri
Neelam Jhaveri edited on 9 May, 2019
Edits made to:
Infobox (+4/-1 properties)
Topic thumbnail

Ascletis, Inc. Ascletis

A biotechnology company that develops and discovers anti-viral drugs and treatments for cancer and fatty liver disease. Ascletis is a joint venture between entrepreneurs in the U.S. and China.

Infobox
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 9 May, 2019
Edits made to:
Infobox (+1 properties)
People (+1 rows) (+2 cells) (+18 characters)
Topic thumbnail

Ascletis Pharma

A biotechnology company that develops and discovers anti-viral drugs and treatments for cancer and fatty liver disease. Ascletis is a joint venture between entrepreneurs in the U.S. and China.

People

Name
Role
Related Golden topics

Eric Huang

Employee

Infobox
Edits on 17 Apr, 2019
Golden AI
Golden AI edited on 17 Apr, 2019
Edits made to:
Description (+7 characters)
Topic thumbnail

Ascletis Pharma

Company

Edits on 7 Mar, 2019
Golden AI
Golden AI edited on 7 Mar, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Edits on 5 Mar, 2019
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 5 Mar, 2019
Edits made to:
Infobox (+2 properties)
Infobox
Location
Chapel Hill, North Carolina
Henry Ogolla"Initial topic creation"
Henry Ogolla created this topic on 5 Mar, 2019
Edits made to:
Topic thumbnail

 Ascletis, Inc.

A biotechnology company that develops and discovers anti-viral drugs and treatments for cancer and fatty liver disease. Ascletis is a joint venture between entrepreneurs in the U.S. and China.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.